BICYCLE THERAPEUTICS PLC BCYC
SPONSORED ADS · ADR · CUSIP 088786108 · ISIN US0887861088
Company in Cambridge, United Kingdom
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersCambridge, United Kingdom
- Founded2009
- Websitebicycletherapeutics.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($667.0k this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $41.59. Options: 5 managers hold calls ($6.6m notional), 3 hold puts ($474.0k).
Trends to Q3 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 11 |
| Q1 2020 | 15 |
| Q2 2020 | 17 |
| Q3 2020 | 19 |
| Q4 2020 | 28 |
| Q1 2021 | 40 |
| Q2 2021 | 55 |
| Q3 2021 | 70 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 6 | 3 |
| Q2 2020 | 8 | 4 |
| Q3 2020 | 5 | 9 |
| Q4 2020 | 16 | 5 |
| Q1 2021 | 26 | 11 |
| Q2 2021 | 33 | 15 |
| Q3 2021 | 35 | 32 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2020 | $0 | $0 | — |
| Q1 2021 | $0 | $0 | — |
| Q2 2021 | $0 | $0 | — |
| Q3 2021 | $6.6m | $474.0k | 0.07 |
Biggest buyers
| Logos Global Management LP | Added | +760.0k |
| First Light Asset Management, LLC | New | +732.7k |
| Ikarian Capital, LLC | New | +526.5k |
| FRAZIER MANAGEMENT LLC | New | +442.9k |
| FMR LLC | Added | +250.2k |
| TWO SIGMA INVESTMENTS, LP | New | +92.2k |
| Altium Capital Management LLC | New | +92.0k |
| MORGAN STANLEY | Added | +78.4k |
| Bellevue Group AG | New | +65.7k |
| BOOTHBAY FUND MANAGEMENT, LLC | New | +54.9k |
Biggest sellers
| FIL Ltd | Sold out | -525.6k |
| SV Health Investors, LLC | Reduced | -478.8k |
| AXA S.A. | Reduced | -196.3k |
| Point72 Asset Management, L.P. | Reduced | -190.8k |
| JANUS HENDERSON GROUP PLC | Reduced | -106.7k |
| Ghost Tree Capital, LLC | Reduced | -100.0k |
| Verition Fund Management LLC | Reduced | -32.6k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -20.4k |
| VICTORY CAPITAL MANAGEMENT INC | Reduced | -16.7k |
| Laurion Capital Management LP | Reduced | -14.6k |
Biggest calls
| Ikarian Capital, LLC | New | $5.4m130.0k shares |
| BOOTHBAY FUND MANAGEMENT, LLC | New | $541.0k13.0k shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | $370.0k8.9k shares |
| CITADEL ADVISORS LLC | New | $241.0k5.8k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | $00 shares |
Biggest puts
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | $262.0k6.3k shares |
| CITADEL ADVISORS LLC | New | $212.0k5.1k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Forbion Growth Opportunities Fund II Cooperatief U.A. 13G · passive investor new · filed 2024-12-19 | 7.3% |
| ARMISTICE CAPITAL, LLC 13G · institution no change · filed 2026-08-14 | 6.7% |
| Long Focus Capital Management, LLC 13G · institution new · filed 2026-05-15 | 6.6% |
Fell to 5% or below in the last year: Invus Global Management, LLC (3.1%, 2026-05-04), WESTFIELD CAPITAL MANAGEMENT CO LP (0.0%, 2026-03-04)
Insider purchases and sales in Q3 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2019 | 0 | — | 0 | — | — |
| Q1 2020 | 0 | — | 0 | — | — |
| Q2 2020 | 0 | — | 0 | — | — |
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 1 | $716.5k | — |
| Q1 2021 | 0 | — | 4 | $2.0m | — |
| Q2 2021 | 0 | — | 2 | $3.8m | — |
| Q3 2021 | 0 | — | 5 | $10.5m | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2021-09-16 | Keen Nicholas Chief Scientific Officer | Sold | $88.0k2.0k shares |
| 2021-09-15 | Keen Nicholas Chief Scientific Officer | Sold | $135.0k3.0k shares |
| 2021-09-02 | Keen Nicholas Chief Scientific Officer | Sold | $400.0k10.0k shares |
| 2021-09-02 | Kalowski Lee President and CFO | Sold | $400.0k10.0k shares |
| 2021-09-02 | Lee Kevin Chief Executive Officer, director | Sold | $200.0k5.0k shares |
| 2021-09-01 | Lee Kevin Chief Executive Officer, director | Sold | $1.0m27.1k shares |
| 2021-08-31 | Lee Kevin Chief Executive Officer, director | Sold | $407.8k11.2k shares |
| 2021-08-27 | Kalowski Lee President and CFO | Sold | $279.4k8.0k shares |
| 2021-08-27 | Lee Kevin Chief Executive Officer, director | Sold | $65.1k1.8k shares |
| 2021-08-26 | Kalowski Lee President and CFO | Sold | $19.3k550 shares |
| 2021-08-23 | Kalowski Lee President and CFO | Sold | $247.7k7.5k shares |
| 2021-07-29 | Kalowski Lee President and CFO | Sold | $393.8k12.5k shares |
| 2021-07-26 | Lee Kevin Chief Executive Officer, director | Sold | $3.6k100 shares |
| 2021-07-23 | Lee Kevin Chief Executive Officer, director | Sold | $172.2k4.8k shares |
| 2021-07-16 | Lee Kevin Chief Executive Officer, director | Sold | $20.7k609 shares |
| 2021-07-15 | Lee Kevin Chief Executive Officer, director | Sold | $753.1k22.0k shares |
| 2021-07-14 | BINGHAM KATE Director · By SV Life Sciences Fund V, L.P. | Sold | $1.5m43.4k shares |
| 2021-07-14 | Lee Kevin Chief Executive Officer, director | Sold | $496.7k14.5k shares |
| 2021-07-14 | Keen Nicholas Chief Scientific Officer | Sold | $350.0k10.0k shares |
| 2021-07-14 | BINGHAM KATE Director · By SV Life Sciences Fund V Strategic Partners, L.P. | Sold | $31.2k917 shares |
| 2021-07-13 | Crockett Nigel Chief Business Officer | Sold | $2.4m72.7k shares |
| 2021-07-13 | Lee Kevin Chief Executive Officer, director | Sold | $1.3m39.0k shares |
| 2021-07-13 | BINGHAM KATE Director · By SV Life Sciences Fund V, L.P. | Sold | $19.7k588 shares |
| 2021-07-13 | BINGHAM KATE Director · By SV Life Sciences Fund V Strategic Partners, L.P. | Sold | $40212 shares |
| 2021-07-12 | Crockett Nigel Chief Business Officer | Sold | $225.1k7.0k shares |
| 2021-07-12 | Lee Kevin Chief Executive Officer, director | Sold | $62.0k1.9k shares |
| 2021-07-06 | Crockett Nigel Chief Business Officer | Sold | $8.7k271 shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2021
| Manager | Shares | Change |
|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2.05% of their portfolio | 2.0m $81.4m | Unchanged |
| JANUS HENDERSON GROUP PLC 0.03% of their portfolio | 1.7m $72.6m | Reduced -106.7k |
| Point72 Asset Management, L.P. 0.32% of their portfolio | 1.6m $67.2m | Reduced -190.8k |
| Logos Global Management LP 4.42% of their portfolio | 1.5m $61.3m | Added +760.0k |
| SV Health Investors, LLC 29.23% of their portfolio | 1.4m $59.7m | Reduced -478.8k |
| EVENTIDE ASSET MANAGEMENT, LLC 0.64% of their portfolio | 1.2m $48.4m | Unchanged |
| First Light Asset Management, LLC 2.01% of their portfolio | 732.7k $30.5m | New |
| Ikarian Capital, LLC 5.01% of their portfolio | 526.5k $21.9m | New |
| FMR LLC 0.00% of their portfolio | 461.6k $19.2m | Added +250.2k |
| SAMLYN CAPITAL, LLC 0.28% of their portfolio | 454.9k $18.9m | Added +11.6k |
| FRAZIER MANAGEMENT LLC 1.47% of their portfolio | 442.9k $18.4m | New |
| Atlas Venture Advisors, Inc. 1.52% of their portfolio | 307.7k $12.8m | Unchanged |
| AXA S.A. 0.02% of their portfolio | 198.7k $8.3m | Reduced -196.3k |
| Verition Fund Management LLC 0.11% of their portfolio | 179.3k $7.5m | Reduced -32.6k |
| VICTORY CAPITAL MANAGEMENT INC 0.01% of their portfolio | 153.7k $6.4m | Reduced -16.7k |
| MORGAN STANLEY 0.00% of their portfolio | 144.6k $6.0m | Added +78.4k |
| Dorsey Wright & Associates 1.17% of their portfolio | 127.8k $5.3m | Added +2.1k |
| Ghost Tree Capital, LLC 1.37% of their portfolio | 100.0k $4.2m | Reduced -100.0k |
| TWO SIGMA INVESTMENTS, LP 0.01% of their portfolio | 92.2k $3.8m | New |
| Altium Capital Management LLC 1.02% of their portfolio | 92.0k $3.8m | New |
| Parkman Healthcare Partners LLC 0.73% of their portfolio | 69.5k $2.9m | Reduced -11.3k |
| Bellevue Group AG 0.03% of their portfolio | 65.7k $2.7m | New |
| Schonfeld Strategic Advisors LLC 0.03% of their portfolio | 60.0k $2.5m | Added +5.1k |
| Moody Aldrich Partners LLC 0.31% of their portfolio | 59.1k $2.5m | Reduced -14.1k |
| BOOTHBAY FUND MANAGEMENT, LLC 0.09% of their portfolio | 54.9k $2.3m | New |
| TWO SIGMA ADVISERS, LP 0.01% of their portfolio | 46.7k $1.9m | New |
| ENVESTNET ASSET MANAGEMENT INC 0.00% of their portfolio | 43.3k $1.8m | Added +631 |
| ACUTA CAPITAL PARTNERS, LLC 0.57% of their portfolio | 38.2k $1.6m | New |
| STIFEL FINANCIAL CORP 0.00% of their portfolio | 37.9k $1.6m | Reduced -4.3k |
| Laurion Capital Management LP 0.02% of their portfolio | 35.1k $1.5m | Reduced -14.6k |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 25.3k $1.1m | New |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 21.2k $878.0k | Added +12.2k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 18.5k $768.0k | New |
| Marshall Wace North America L.P. 0.00% of their portfolio | 17.5k $726.0k | New |
| Jump Financial, LLC 0.05% of their portfolio | 17.2k $715.0k | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 14.9k $618.0k | New |
| Cutler Group LLC / CA 0.05% of their portfolio | 14.6k $608.0k | New |
| Pentwater Capital Management LP 0.01% of their portfolio | 12.0k $499.0k | Unchanged |
| WOODSTOCK CORP 0.05% of their portfolio | 10.7k $444.0k | New |
| Legal & General Group Plc 0.00% of their portfolio | 10.2k $423.0k | Added +2.2k |
| US BANCORP \DE\ 0.00% of their portfolio | 10.0k $416.0k | Reduced -2.8k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 9.9k $410.0k | Added +2.4k |
| Vestmark Advisory Solutions, Inc. 0.03% of their portfolio | 9.9k $411.0k | Reduced -178 |
| WRAPMANAGER INC 0.10% of their portfolio | 9.6k $400.0k | Reduced -46 |
| Bank of New York Mellon Corp 0.00% of their portfolio | 8.5k $353.0k | Reduced -3.6k |
| TOWNSQUARE CAPITAL LLC 0.01% of their portfolio | 7.8k $324.0k | Reduced -41 |
| MARSHALL WACE, LLP 0.00% of their portfolio | 7.7k $320.0k | Unchanged |
| PERSONAL CFO SOLUTIONS, LLC 0.06% of their portfolio | 7.6k $314.0k | Added +273 |
| TRUIST FINANCIAL CORP 0.00% of their portfolio | 7.4k $307.0k | Added +252 |
| VIRTUS ADVISERS, LLC 0.13% of their portfolio | 7.1k $297.0k | Reduced -379 |
| STATE STREET CORP 0.00% of their portfolio | 6.7k $279.0k | New |
| GLENMEDE TRUST CO NA 0.00% of their portfolio | 6.4k $267.0k | Reduced -3.1k |
| BARCLAYS PLC 0.00% of their portfolio | 6.1k $255.0k | Added +1.5k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 6.1k $254.0k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 5.1k $210.0k | Reduced -13.1k |
| State of New Jersey Common Pension Fund D 0.00% of their portfolio | 4.9k $203.0k | New |
| KBC Group NV 0.00% of their portfolio | 3.8k $156.0k | Reduced -3.8k |
| CAPTRUST FINANCIAL ADVISORS 0.00% of their portfolio | 2.3k $94.0k | Reduced -1.0k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 2.2k $90.0k | Reduced -176 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 1.4k $57.0k | Reduced -691 |
| UBS Group AG 0.00% of their portfolio | 846 $35.0k | Reduced -869 |
| HighMark Wealth Management LLC 0.02% of their portfolio | 626 $26.0k | New |
| Rockefeller Capital Management L.P. 0.00% of their portfolio | 346 $14.0k | New |
| CITIGROUP INC 0.00% of their portfolio | 153 $6.0k | Reduced -913 |
| Evolution Wealth Advisors, LLC 0.00% of their portfolio | 120 $5.0k | Reduced -277 |
| American Portfolios Advisors 0.00% of their portfolio | 114 $4.7k | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 104 $4.0k | New |
| NFSG Corp 0.00% of their portfolio | 40 $2.0k | Unchanged |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 1 $0 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |